Trademark: 88705137
Status Date
Monday, January 11, 2021
Filing Date
Monday, November 25, 2019
Published for Opposition
Tuesday, November 17, 2020
Abandoned Date
Monday, January 11, 2021
5 Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection
Jan 11, 2021
Abandonment Notice E-Mailed - After Publication
Jan 11, 2021
Abandonment - After Publication
Jan 7, 2021
Teas Express Abandonment Received
Nov 17, 2020
Extension Of Time To Oppose Received
Nov 17, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2020
Published For Opposition
Oct 28, 2020
Notification Of Notice Of Publication E-Mailed
Oct 15, 2020
Approved For Pub - Principal Register
Oct 15, 2020
Notification Of Examiners Amendment E-Mailed
Oct 15, 2020
Examiners Amendment E-Mailed
Oct 15, 2020
Examiners Amendment -Written
Oct 1, 2020
Teas/Email Correspondence Entered
Oct 1, 2020
Correspondence Received In Law Office
Oct 1, 2020
Assigned To Lie
Aug 27, 2020
Teas Response To Office Action Received
Jul 23, 2020
Assigned To Examiner
Mar 3, 2020
Notification Of Non-Final Action E-Mailed
Mar 3, 2020
Non-Final Action E-Mailed
Mar 3, 2020
Non-Final Action Written
Feb 28, 2020
Assigned To Examiner
Dec 3, 2019
New Application Office Supplied Data Entered In Tram
Nov 28, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
